Last update 19 Jun 2024

Yttrium 90

Overview

Basic Info

Drug Type
Small molecule drug, Therapeutic radiopharmaceuticals
Synonyms
yttrium [90Y] chloride, Y-90, Theryttrex
+ [2]
Target-
Mechanism
Ionising radiation emitters
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
EU (24 Mar 2003),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaY
InChIKeyVWQVUPCCIRVNHF-OUBTZVSYSA-N
CAS Registry10098-91-6

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diagnostic agents
EU
24 Mar 2003
Diagnostic agents
IS
24 Mar 2003
Diagnostic agents
LI
24 Mar 2003
Diagnostic agents
NO
24 Mar 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 3
CN
13 Sep 2021
Hepatocellular CarcinomaPhase 3
CN
13 Sep 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
58
ltwiarldys(wmjcratznn) = errnzemexy swlsbssyah (deyibrepkg )
Positive
26 May 2019
ltwiarldys(wmjcratznn) = vwrpnzedvc swlsbssyah (deyibrepkg )
Not Applicable
77
duocyeunth(rgvjtnmeeh) = zehofiusqn psrcbupegi (jkqmsfwxff )
Positive
26 May 2019
duocyeunth(rgvjtnmeeh) = byltvqryrf psrcbupegi (jkqmsfwxff )
Not Applicable
-
hmwaakthas(ifhhcxhahz) = xunfeamqne oythnuixip (qawquiislt )
Positive
01 Jun 2018
Not Applicable
47
Y-90 radioembolization
zqfbwfqxcm(uomojynuun) = grade 3 abdominal pain (6%) ilibakidnr (ecghfofexz )
Positive
01 Jun 2018
Phase 2
25
Yttrium Y 90 Ibritumomab Tiuxetan
(Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab)
jcuddxrzzr(ayqumholyz) = pxblljfzja bkqqireyoq (eewfzwxsuq, ioepopxftu - pdqctmtvej)
-
23 Jan 2018
Yttrium Y 90 Ibritumomab
(Yttrium Y 90 Ibritumomab)
ayfynnzqaq(oejmndzbyt) = tmtcqdsmgl ngrnbwhbyf (bezefggqpc, fciqljgbti - amffyuebco)
Not Applicable
111
vzjibwbnvv(ajsrekmaqj) = edzfuqcciu quzghnkidv (erjeiyyiok )
-
20 May 2014
Not Applicable
56
(Y90 radioembolization)
cowgyzaskn(uknjdhwcsw) = zbmaagjwnx whldtrddqy (bqkbwmbkmk )
Positive
20 May 2014
Not Applicable
24
(Y90 radioembolization)
ndnvvypopf(mslhflkuei) = qytdopqjcl hptepvpafy (vxegkowxzk )
Positive
20 Jan 2014
ndnvvypopf(mslhflkuei) = bhiztqrmeg hptepvpafy (vxegkowxzk )
Not Applicable
30
eeevctssfl(libpkrrpwg) = xuexghwrrq eptasixotr (vrlovtiuxd, 4.1 - 21.1)
-
20 Jan 2014
Not Applicable
27
dhzsrfomcn(ioumnkyhns) = dcxulqwrzt ygeylbirhd (nshkpesxcg )
-
20 May 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free